- Home
- AXSM vs FRT Comparison
AXSM vs FRT Comparison
Compare AXSM & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | FRT |
|---|---|---|
| Founded | 2012 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | FRT |
|---|---|---|
| Price | $191.00 | $103.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | ★ $190.57 | $110.14 |
| AVG Volume (30 Days) | ★ 867.9K | 573.2K |
| Earning Date | 02-17-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 4.41% |
| EPS Growth | N/A | ★ 14.84 |
| EPS | N/A | ★ 3.95 |
| Revenue | $561,263,000.00 | ★ $1,257,396,000.00 |
| Revenue This Year | $67.10 | $5.67 |
| Revenue Next Year | $58.73 | $5.18 |
| P/E Ratio | ★ N/A | $25.97 |
| Revenue Growth | ★ 65.83 | 6.11 |
| 52 Week Low | $86.99 | $80.65 |
| 52 Week High | $189.34 | $111.82 |
Technical Indicators
Market Signals| Indicator | AXSM | FRT |
|---|---|---|
| Relative Strength Index (RSI) | 72.77 | 60.24 |
| Support Level | $172.05 | $101.48 |
| Resistance Level | $179.00 | $103.82 |
| Average True Range (ATR) | 6.68 | 1.61 |
| MACD | 1.41 | 0.05 |
| Stochastic Oscillator | 99.42 | 91.26 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 27.4 million square feet of retail space and 3,000 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.